Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bimetric-10: Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-Metric Stem

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier:
NCT00192699
First received: September 11, 2005
Last updated: March 28, 2014
Last verified: March 2014
  Purpose

This is a 10 year follow-up investigation of patients who have underwent total hip arthroplasty with a cemented Bimetric stem.


Condition Intervention
Osteoarthrosis
Device: Bimetric femoral stem

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: 10 Year Follow-up Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-metric Stem

Resource links provided by NLM:


Further study details as provided by Northern Orthopaedic Division, Denmark:

Enrollment: 80
Study Start Date: January 2004
Study Completion Date: April 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Group 1: Cemented Bi-Metric femoral stem
Cemented Bi-Metric femoral stem
Device: Bimetric femoral stem
Cemented Bi-Metric femoral stem
Other Name: Cemented Bi-Metric femoral stem

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with osteoarthrosis in hip who have underwent surgery for 10 years ago using Cemented Bi-Metric femoral stem.

Criteria

Inclusion criteria:

  • Osteoarthrosis

Exclusion criteria:

  • Malignancies
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00192699

Locations
Denmark
Northern Orthopaedic Division, Aalborg University Hospital
Aalborg, Northern Jutland, Denmark, 9000
Sponsors and Collaborators
Northern Orthopaedic Division, Denmark
Investigators
Principal Investigator: Mogens B Laursen, MD, PhD Northern Orthopaedic Division, Aalborg University Hospital, Denmark
  More Information

No publications provided

Responsible Party: Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier: NCT00192699     History of Changes
Other Study ID Numbers: ON-04-008b-JPE
Study First Received: September 11, 2005
Last Updated: March 28, 2014
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics
Denmark: Danish Dataprotection Agency

Keywords provided by Northern Orthopaedic Division, Denmark:
Osteoarthritis

Additional relevant MeSH terms:
Joint Diseases
Osteoarthritis
Arthritis
Musculoskeletal Diseases
Rheumatic Diseases
Metronidazole
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Radiation-Sensitizing Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on November 25, 2014